Boya Peng

1.9k total citations · 2 hit papers
25 papers, 1.5k citations indexed

About

Boya Peng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Boya Peng has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Boya Peng's work include Extracellular vesicles in disease (11 papers), RNA Interference and Gene Delivery (7 papers) and MicroRNA in disease regulation (7 papers). Boya Peng is often cited by papers focused on Extracellular vesicles in disease (11 papers), RNA Interference and Gene Delivery (7 papers) and MicroRNA in disease regulation (7 papers). Boya Peng collaborates with scholars based in China, Singapore and Hong Kong. Boya Peng's co-authors include Minh T. N. Le, Migara Kavishka Jayasinghe, William C. Cho, Victor Ma, Luyen Tien Vu, Tin Chanh Pham, Jiahai Shi, Likun Wei, Anskar Y.H. Leung and Ng Shyh‐Chang and has published in prestigious journals such as Nature Communications, Blood and ACS Nano.

In The Last Decade

Boya Peng

24 papers receiving 1.4k citations

Hit Papers

Efficient RNA drug delivery using red blood cell extracel... 2018 2026 2020 2023 2018 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boya Peng China 15 1.2k 580 261 193 100 25 1.5k
Shilpa Prabhakar United States 15 1.2k 1.0× 668 1.2× 207 0.8× 193 1.0× 58 0.6× 22 1.6k
Daniel W. Hagey Sweden 16 1.2k 1.0× 503 0.9× 192 0.7× 147 0.8× 67 0.7× 25 1.4k
Rajesh Mukthavaram United States 20 899 0.8× 467 0.8× 202 0.8× 138 0.7× 187 1.9× 39 1.4k
Huafeng Zhang China 18 937 0.8× 532 0.9× 288 1.1× 416 2.2× 68 0.7× 24 1.5k
Victor Ma China 9 889 0.7× 491 0.8× 166 0.6× 101 0.5× 43 0.4× 16 1.0k
Tin Chanh Pham Hong Kong 7 774 0.7× 403 0.7× 166 0.6× 156 0.8× 51 0.5× 8 928
Bong Hwan Sung United States 15 1.2k 1.0× 581 1.0× 153 0.6× 192 1.0× 28 0.3× 22 1.5k
Shinobu Ueda Japan 13 1.8k 1.5× 1.2k 2.0× 192 0.7× 134 0.7× 66 0.7× 20 2.0k
Linan Liu United States 12 926 0.8× 379 0.7× 194 0.7× 87 0.5× 109 1.1× 20 1.3k
Kellye C. Kirkbride United States 15 1.5k 1.3× 528 0.9× 140 0.5× 174 0.9× 111 1.1× 18 1.9k

Countries citing papers authored by Boya Peng

Since Specialization
Citations

This map shows the geographic impact of Boya Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boya Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boya Peng more than expected).

Fields of papers citing papers by Boya Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boya Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boya Peng. The network helps show where Boya Peng may publish in the future.

Co-authorship network of co-authors of Boya Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Boya Peng. A scholar is included among the top collaborators of Boya Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boya Peng. Boya Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi, Kaiming, Boya Peng, Trudy Millard Krause, et al.. (2025). Modeling the Impact of MMR Vaccination Strategies on Measles Outbreaks in Texas. JAMA Health Forum. 6(9). e253992–e253992.
2.
Peng, Boya, Dajian Li, Wei Zhang, et al.. (2024). Study on the cracking process of epoxy resin under oxygen and water atmosphere based on ReaxFF force field. AIP Advances. 14(9). 1 indexed citations
3.
Gao, Chang, Dong Van Hoang, Thach Tuan Pham, et al.. (2024). Extracellular vesicle surface display enhances the therapeutic efficacy and safety profile of cancer immunotherapy. Molecular Therapy. 32(10). 3558–3579. 7 indexed citations
4.
Pham, Thach Tuan, Cong Phi Dang, Suet Yen Chong, et al.. (2023). Endocytosis of red blood cell extracellular vesicles by macrophages leads to cytoplasmic heme release and prevents foam cell formation in atherosclerosis. Journal of Extracellular Vesicles. 12(8). 19 indexed citations
5.
Nguyen, Phuong H. D., et al.. (2023). Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles. ACS Nano. 17(6). 5187–5210. 132 indexed citations breakdown →
7.
Peng, Boya, Yuqi Yang, Zhiyuan Wu, et al.. (2023). Red blood cell extracellular vesicles deliver therapeutic siRNAs to skeletal muscles for treatment of cancer cachexia. Molecular Therapy. 31(5). 1418–1436. 20 indexed citations
8.
Peng, Boya, Migara Kavishka Jayasinghe, Chang Gao, et al.. (2022). Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy. Journal of Extracellular Vesicles. 11(4). e12187–e12187. 67 indexed citations
9.
Jayasinghe, Migara Kavishka, Marco Pirisinu, Yuqi Yang, et al.. (2022). Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy. Theranostics. 12(7). 3288–3315. 44 indexed citations
10.
Jayasinghe, Migara Kavishka, Boya Peng, Yuqi Yang, et al.. (2021). New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies. Seminars in Cancer Biology. 74. 62–78. 49 indexed citations
11.
Pham, Tin Chanh, Migara Kavishka Jayasinghe, Thach Tuan Pham, et al.. (2021). Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery. Journal of Extracellular Vesicles. 10(4). e12057–e12057. 173 indexed citations
12.
Peng, Boya, et al.. (2020). Essential functions of miR‐125b in cancer. Cell Proliferation. 54(2). e12913–e12913. 59 indexed citations
13.
Wu, Yi, Jing Zhang, Boya Peng, et al.. (2019). Generating viable mice with heritable embryonically lethal mutations using the CRISPR-Cas9 system in two-cell embryos. Nature Communications. 10(1). 2883–2883. 26 indexed citations
14.
Vu, Luyen Tien, Boya Peng, Daniel Xin Zhang, et al.. (2019). Tumor‐secreted extracellular vesicles promote the activation of cancer‐associated fibroblasts via the transfer of microRNA‐125b. Journal of Extracellular Vesicles. 8(1). 1599680–1599680. 123 indexed citations
15.
Pham, Tin Chanh, Luyen Tien Vu, Victor Ma, et al.. (2018). Efficient RNA drug delivery using red blood cell extracellular vesicles. Nature Communications. 9(1). 2359–2359. 516 indexed citations breakdown →
16.
Liu, Bing, Xinping Huang, Yunlong Hu, et al.. (2016). Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer. Oncotarget. 7(36). 58038–58050. 22 indexed citations
17.
Wang, Xiaodong, Dong Gao, Yu Liu, et al.. (2015). Antitumor activity of a novel small molecule TLR7 agonist via immune response induction and tumor microenvironment modulation. Oncology Reports. 35(2). 793–800. 9 indexed citations
18.
Peng, Boya, Chunmei Guo, Hongwei Guan, Shuqing Liu, & Ming‐Zhong Sun. (2013). Annexin A5 as a potential marker in tumors. Clinica Chimica Acta. 427. 42–48. 91 indexed citations
19.
Kim, Ki Woo, Shen Li, Hongyu Zhao, et al.. (2010). CNS-Specific Ablation of Steroidogenic Factor 1 Results in Impaired Female Reproductive Function. The Journal of Clinical Endocrinology & Metabolism. 95(4). 2007–2007. 3 indexed citations
20.
Drevs, Joachim, Petra Reusch, Boya Peng, et al.. (1999). Phase I dose escalation, pharmacokinetic (pk) study of a novel vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK). European Journal of Cancer. 35. S283–S283. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026